Literature DB >> 29167024

Evolving treatment of necrotizing pancreatitis.

Alexandra M Roch1, Thomas Maatman1, Rose A Carr1, Jeffrey J Easler2, C Max Schmidt1, Michael G House1, Attila Nakeeb1, Eugene P Ceppa1, Nicholas J Zyromski3.   

Abstract

BACKGROUND: Over the past decade, the treatment of necrotizing pancreatitis (NP) has incorporated greater use of minimally invasive techniques, including percutaneous drainage and endoscopic debridement. No study has yet compared outcomes of patients treated with all available techniques. We sought to evaluate the evolution of NP treatment at our high volume pancreas center. We hypothesized that minimally invasive techniques (medical only, percutaneous, and endoscopic) were used more frequently in later years.
METHODS: Treatment strategy of NP patients at a single academic medical center between 2005 and 2014 was reviewed. Definitive management of pancreatic necrosis was categorized as: 1) medical treatment only; 2) surgical only; 3) percutaneous (interventional radiology - IR) only; 4) endoscopic only; and 5) combination (Surgery ± IR ± Endoscopy).
RESULTS: 526 NP patients included biliary (45%), alcoholic (17%), and idiopathic (20%) etiology. Select patients were managed exclusively by medical, IR, or endoscopic treatment; use of these therapies remained relatively consistent over time. A combination of therapies was used in about 30% of patients. Over time, the percentage of NP patients managed without operation increased from 28% to 41%. 247 (47%) of patients had operation as the only NP treatment; an additional 143 (27%) required surgery as part of a multidisciplinary management.
CONCLUSION: Select NP patients may be managed exclusively by medical, IR, or endoscopic treatment. Combination treatment is necessary in many NP patients, and surgical treatment continues to play an important role in the definitive therapy of necrotizing pancreatitis patients.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2017        PMID: 29167024     DOI: 10.1016/j.amjsurg.2017.11.020

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

1.  Venous Thromboembolism in Necrotizing Pancreatitis: an Underappreciated Risk.

Authors:  Alexandra M Roch; Thomas K Maatman; Rose A Carr; Cameron L Colgate; Eugene P Ceppa; Michael G House; James Lopes; Attila Nakeeb; C Max Schmidt; Nicholas J Zyromski
Journal:  J Gastrointest Surg       Date:  2019-02-07       Impact factor: 3.452

2.  Visceral artery pseudoaneurysm in necrotizing pancreatitis: incidence and outcomes.

Authors:  Thomas K Maatman; Mark A Heimberger; Kyle A Lewellen; Alexandra M Roch; Cameron L Colgate; Michael G House; Attila Nakeeb; Eugene P Ceppa; C Max Schmidt; Nicholas J Zyromski
Journal:  Can J Surg       Date:  2020-05-21       Impact factor: 2.089

3.  Open Pancreatic Debridement in Necrotizing Pancreatitis.

Authors:  Thomas K Maatman; Nicholas J Zyromski
Journal:  J Gastrointest Surg       Date:  2020-08-10       Impact factor: 3.452

4.  Outcomes from different minimally invasive approaches for infected necrotizing pancreatitis.

Authors:  Yong Hu; Xun Jiang; Chunyan Li; Yunfeng Cui
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

5.  Management of pancreatic walled-off necrosis using an ultrasonic pneumatic lithotripsy system and double-catheter aspirated lavage performed through drainage tract: a case report.

Authors:  Bei Lu; Junjie Yin; Jingrui Wang; Yang Cai; Xiao Xu
Journal:  J Int Med Res       Date:  2022-03       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.